, Volume 36, Issue 3, pp 205-207

No evidence for increased tumor rates below 200 mSv in the atomic bomb survivors data

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

We investigated for which doses a significantly increased tumor rate can be seen in the RERF Life Span Study data sets on mortality or incidence of solid tumors. No significant increase was found below about 200 mSv.

Received: 28 April 1997 / Accepted in revised form: 2 June 1997